Supplementary Figure S2 from The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading

Supplementary Figure S2 shows the antitumor activity of MRTX0902 in the LN229 (PTPN11 A72S-mutant) model, with tumor growth inhibition data displayed in Figure S2A and ERK phosphorylation graphed in Figure S2B.